# EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)

> **NCT04808661** · NA · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 154 (estimated)

## Conditions studied

- Intramural Hematoma

## Interventions

- **PROCEDURE:** Thoracic endovascular aortic repair plus optimal medical therapy
- **DRUG:** Optimal medical therapy

## Key facts

- **NCT ID:** NCT04808661
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2021-06-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04808661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04808661, "EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04808661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*